A Performance Comparison of Commonly Used Assays to Detect RET Fusions
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-3208
Abstract: Purpose: Selpercatinib and pralsetinib induce deep and durable responses in patients with advanced RET fusion–positive lung and thyroid cancer. RET fusion testing strategies with rapid and reliable results are critical given recent FDA approval. Here,… read more here.
Keywords: dna; performance; fusion; svus ... See more keywords